Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4301 USD | -2.88% | -6.48% | -64.16% |
Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
Mar. 19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
Sales 2023 * | 48.62M 52.36M | Sales 2024 * | 59.5M 64.07M | Capitalization | 11.46M 12.34M |
---|---|---|---|---|---|
Net income 2023 * | -48M -51.69M | Net income 2024 * | -45M -48.46M | EV / Sales 2023 * | 0.24 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.19 x |
P/E ratio 2023 * |
-0.26
x | P/E ratio 2024 * |
-0.42
x | Employees | 444 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.49% |
1 day | -2.88% | ||
1 week | -6.48% | ||
Current month | +2.40% | ||
1 month | -37.67% | ||
3 months | -59.27% | ||
6 months | -65.77% | ||
Current year | -64.16% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Stratton
CEO | Chief Executive Officer | 62 | 21-12-19 |
Director of Finance/CFO | - | 22-02-07 | |
Chief Tech/Sci/R&D Officer | 64 | 21-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peer Schatz
CHM | Chairman | 57 | 20-03-15 |
Hubert Birner
BRD | Director/Board Member | 57 | 17-06-30 |
Flemming Ørnskov
BRD | Director/Board Member | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.4301 | -2.88% | 60 642 |
24-05-03 | 0.4429 | +2.04% | 7,379 |
24-05-02 | 0.434 | -1.36% | 13,888 |
24-05-01 | 0.44 | +4.76% | 3,596 |
24-04-30 | 0.42 | -8.68% | 89,471 |
Delayed Quote Nasdaq, May 06, 2024 at 03:19 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.16% | 12.34M | |
+22.28% | 47.9B | |
+46.56% | 41.42B | |
-2.20% | 40.7B | |
-6.20% | 28.92B | |
+11.08% | 25.55B | |
-21.43% | 19.27B | |
-0.96% | 12.15B | |
+30.55% | 12.14B | |
-0.93% | 11.99B |
- Stock Market
- Equities
- CNTG Stock